Discovery Company Webinar
12 December 5:00pm

InvestorHub Discovery Series

ShareSoc, in collaboration with InvestorHub, presents a new webinar series designed to spotlight small and midcap companies listed on AIM or the Aquis Exchange, with the aim of providing insights into innovative and high-growth prospects within the market.

In December we are pleased to feature Crimson Tide plc (AIM: TIDE) and Fusion Antibodies (FAB).

 

Crimson Tide plc (AIM: TIDE)

Crimson Tide is a leading provider of mobile process management solutions through its flagship platform, mpro5. Established in 1996, the company has grown into a key player in the process management software sector, serving industries such as facilities management, food safety, and retail.
The mpro5 app is a powerful tool for businesses looking to optimise their operations, offering real-time data collection, task automation, and advanced reporting through a world-class mobile interface. Its flexibility allows organisations to digitise their specific workflows, improve compliance, and enhance overall efficiency, managing and solving the problems at the heart of their daily operations.
The upcoming Discovery webinar will feature insights from the company’s leadership team on its vision, innovation strategy, and growth plans.

Presenter: Phil Meyers, CEO

Fusion Antibodies plc (FAB)

Fusion Antibodies is a Belfast based, revenue generating CRO providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications. The Company’s mission is ‘to get better antibodies to the clinic more rapidly’ and so enable biopharmaceutical and diagnostic companies to develop innovative products in a timely and cost-effective manner for the benefit of global healthcare. Clients of the Company are developing a number of new drugs in which the Company has been involved.

Presenter: Dr Adrian Kinkaid, CEO
Adrian has over twenty-six years’ experience working in the bioscience sector. He holds a PhD in Biochemistry from University of Southampton and has expertise in development and commercialisation of all the main classes of affinity reagents. He joined Fusion Antibodies as CEO in August 2022.

Registration

If you are already a member of ShareSoc you must log in prior to registering, then just click “REGISTER” below. If you are not already a member of ShareSoc, please complete the form below to sign up as an Associate (free) member and then click “REGISTER”.

Click here for help on logging in.

Once you have registered you will receive an email notification, as well as reminders 1 day and 1 hour before the event starts.

Register for Webinar

Add to calendar
Event Details:
  • Event: Discovery Company Webinar - 12 December
  • Date: 12/12/2024
  • Time: Presentations Start at 5pm
  • Location: Webinar
Add to calendar
Event Details:
  • Event Discovery Company Webinar - 12 December
  • Date 12/12/2024
  • Time Presentations Start at 5pm
  • Location Webinar
  • Description Companies presenting:
    Crimson Tide plc (AIM: TIDE)
    Fusion Antibodies (FAB)